RAP 0.00% 20.5¢ raptor resources limited

Ann: ResApp Provides Update on SMARTCOUGH-C-2 Study Timing, page-19

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,769 Posts.
    lightbulb Created with Sketch. 1149
    Here is something to ponder in case you have the jitters.

    What is the ONLY difference between the Aussie trials and the USA trials?

    Same app.
    Same improved processes.
    Same dynamic in subject inclusion/exclusion.

    Not much difference except the country it is taking place in.

    Now unless through some miracle of the creator or however us humans got here, that people in the USA and Australia have different coughs, then you would have to expect that the USA results would mirror the Aussie results we have already been given.

    So really...the only chance of a fail here is based in genetics, and that is a finite science that will probably say that there is absolutely no possible way that the coughs are different country to country.

    So its time to relax safe in this knowledge.

    Everything else you can think of is just time wasting because its a worry that shouldn't exist.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.